Aug 27, 2025, 9:18 AM
Biomedical Research
LEXINGTON, Ky. (Aug. 27, 2025) — University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer. The findings of the study, published in the Journal of Clinical Investigation, could lead to new treatment approaches for patients whose cancers no longer respond to hormone therapy.